Topic Highlight
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2014; 20(12): 3255-3264
Published online Mar 28, 2014. doi: 10.3748/wjg.v20.i12.3255
Figure 1
Figure 1 Pathogenesis of inflammatory bowel disease. DC: Dendritic cell; NK: Natural killer; Th: T helper; Treg: T regulator cell; CTL: Cytotoxic T lymphocyte; Mf: Macrophages.
Figure 2
Figure 2 Pleiotropic role of interleukin-21 in immune responses. IFN: Interferon; IL: Interleukin; CD: Crohn’s disease; DC: Dendritic cell; NK: Natural killer; CTL: Cytotoxic T lymphocyte.
Figure 3
Figure 3 Overexpression of interleukin-23 in inflamed mucosa of patients with inflammatory bowel disease weakens the intestinal defensive barrier and disturbs the immune regulation in intestinal mucosa. IEL: Intestinal epithelial lymphocyte; IL: Interleukin; Th: T helper; Treg: T regulator cell; DC: Dendritic cell.
Figure 4
Figure 4 Inhibitory role of interleukin-25 in intestinal mucosa. IEL: Intestinal epithelial lymphocyte; IL: Interleukin; Th: T helper; Treg: T regulator cell; CTL: Cytotoxic T lymphocyte; Mf: Macrophages; IEC: Intestinal epithelial cells; IBD: Inflammatory bowel disease.